Acutus Medical Inc
OTC:AFIB
Cash Flow Statement
Cash Flow Statement
Acutus Medical Inc
| Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||||||
| Net Income |
(124)
|
(155)
|
(102)
|
(113)
|
(119)
|
(116)
|
(118)
|
(129)
|
(94)
|
(86)
|
(40)
|
(16)
|
(40)
|
(33)
|
(82)
|
(67)
|
(50)
|
(42)
|
(10)
|
|
| Depreciation & Amortization |
3
|
4
|
3
|
4
|
5
|
6
|
6
|
7
|
7
|
7
|
6
|
6
|
6
|
5
|
0
|
(1)
|
(2)
|
(3)
|
0
|
|
| Stock-Based Compensation |
3
|
9
|
12
|
13
|
16
|
13
|
14
|
14
|
13
|
11
|
3
|
1
|
(0)
|
(2)
|
3
|
2
|
1
|
0
|
0
|
|
| Other Non-Cash Items |
40
|
51
|
20
|
23
|
23
|
15
|
15
|
29
|
(7)
|
(11)
|
(55)
|
(69)
|
(35)
|
(36)
|
22
|
8
|
2
|
7
|
(18)
|
|
| Cash Taxes Paid |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Interest Paid |
6
|
7
|
5
|
5
|
5
|
4
|
4
|
4
|
4
|
4
|
4
|
4
|
5
|
5
|
5
|
5
|
5
|
5
|
5
|
|
| Change in Working Capital |
(1)
|
(7)
|
(6)
|
(8)
|
(10)
|
(6)
|
(4)
|
(8)
|
(6)
|
(4)
|
3
|
5
|
4
|
5
|
(4)
|
(4)
|
(7)
|
(7)
|
(4)
|
|
| Cash from Operating Activities |
(81)
N/A
|
(107)
-32%
|
(85)
+21%
|
(94)
-10%
|
(100)
-7%
|
(101)
-1%
|
(100)
+2%
|
(101)
-1%
|
(100)
+1%
|
(95)
+6%
|
(85)
+10%
|
(74)
+13%
|
(65)
+12%
|
(58)
+11%
|
(63)
-9%
|
(64)
-1%
|
(56)
+12%
|
(46)
+18%
|
(32)
+31%
|
|
| Investing Cash Flow | ||||||||||||||||||||
| Capital Expenditures |
(8)
|
(11)
|
(11)
|
(13)
|
(13)
|
(10)
|
(10)
|
(7)
|
(6)
|
(6)
|
(4)
|
(3)
|
(3)
|
(3)
|
(0)
|
(0)
|
1
|
1
|
(0)
|
|
| Other Items |
(18)
|
(122)
|
(53)
|
(70)
|
(70)
|
31
|
29
|
30
|
80
|
87
|
109
|
107
|
49
|
62
|
59
|
53
|
41
|
27
|
22
|
|
| Cash from Investing Activities |
(26)
N/A
|
(133)
-413%
|
(64)
+52%
|
(83)
-31%
|
(82)
+1%
|
21
N/A
|
19
-9%
|
23
+20%
|
74
+224%
|
81
+9%
|
105
+29%
|
104
-1%
|
46
-56%
|
60
+30%
|
59
-2%
|
53
-10%
|
42
-20%
|
28
-33%
|
22
-21%
|
|
| Financing Cash Flow | ||||||||||||||||||||
| Net Issuance of Common Stock |
67
|
233
|
167
|
167
|
167
|
84
|
84
|
84
|
83
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(0)
|
0
|
0
|
|
| Net Issuance of Debt |
59
|
59
|
(3)
|
(2)
|
(3)
|
(3)
|
(3)
|
(1)
|
(11)
|
(11)
|
(11)
|
(10)
|
(0)
|
(2)
|
(2)
|
0
|
(5)
|
(3)
|
(3)
|
|
| Other |
(3)
|
0
|
0
|
0
|
(0)
|
(1)
|
(1)
|
0
|
(3)
|
(2)
|
(2)
|
(2)
|
(0)
|
(0)
|
(1)
|
(1)
|
(1)
|
(1)
|
(0)
|
|
| Cash from Financing Activities |
123
N/A
|
290
+136%
|
164
-43%
|
165
+0%
|
165
+0%
|
81
-51%
|
80
-1%
|
82
+3%
|
70
-14%
|
(13)
N/A
|
(12)
+4%
|
(12)
-1%
|
(1)
+94%
|
(2)
-208%
|
(3)
-22%
|
(2)
+6%
|
(5)
-104%
|
(3)
+38%
|
(3)
+9%
|
|
| Change in Cash | ||||||||||||||||||||
| Effect of Foreign Exchange Rates |
(0)
|
0
|
0
|
0
|
0
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(0)
|
(1)
|
(0)
|
2
|
2
|
2
|
2
|
0
|
|
| Net Change in Cash |
16
N/A
|
50
+210%
|
16
-69%
|
(12)
N/A
|
(17)
-39%
|
0
N/A
|
(1)
N/A
|
4
N/A
|
43
+1 078%
|
(26)
N/A
|
7
N/A
|
17
+144%
|
(21)
N/A
|
(1)
+95%
|
(5)
-394%
|
(11)
-122%
|
(17)
-47%
|
(19)
-11%
|
(12)
+34%
|
|
| Free Cash Flow | ||||||||||||||||||||
| Free Cash Flow |
(89)
N/A
|
(119)
-33%
|
(96)
+19%
|
(107)
-11%
|
(113)
-5%
|
(111)
+2%
|
(110)
+1%
|
(108)
+1%
|
(106)
+2%
|
(100)
+5%
|
(89)
+11%
|
(77)
+13%
|
(69)
+11%
|
(61)
+11%
|
(63)
-4%
|
(64)
0%
|
(55)
+13%
|
(45)
+19%
|
(32)
+29%
|
|